Kronos Bio, Inc. Proceeds from Convertible Debt
Kronos Bio, Inc. reported Proceeds from Convertible Debt of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2022-02-24
- Kronos Bio, Inc. proceeds from convertible debt for the quarter ending 2021-12-31 was $0.00.
- Kronos Bio, Inc. proceeds from convertible debt for the quarter ending 2020-12-31 was $0.00.
- Kronos Bio, Inc. proceeds from convertible debt for the quarter ending 2019-12-31 was $0.00.
- Kronos Bio, Inc. proceeds from convertible debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Kronos Bio, Inc. proceeds from convertible debt for fiscal 2020 was $151.28M.
- Kronos Bio, Inc. proceeds from convertible debt for fiscal 2019 was $0.00.
- Kronos Bio, Inc. proceeds from convertible debt for fiscal 2018 was $0.00.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $151.28M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $151.28M 10-Q · filed 2021-11-09 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-18 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-23 |